Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
Go back to Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update| (NASDAQ: TSHA) | Delayed: 6.94 +0.08 (1.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.86 | 52 Week High | $ | |||
| Open | $6.86 | 52 Week Low | $ | |||
| Day High | $7.06 | P/E | N/A | |||
| Day Low | $6.83 | EPS | $ | |||
| Volume | 2,073,490 | |||||
